Where does Elantas PDG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Elantas PDG ranks #26,205 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Elantas PDG hold?

Elantas PDG holds 10 US utility patents granted between 2017 and 2025, spanning 15 technology areas.

What is Elantas PDG's Innovation Score?

Elantas PDG has an Innovation Score of 34.8 out of 100 (49th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Elantas PDG's patent grant rate increasing or decreasing?

Elantas PDG's recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Elantas PDG's patents?

Elantas PDG's patents average 19.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Elantas PDG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Elantas PDG

Q: What technology areas does Elantas PDG focus on?

Elantas PDG's top technology area is C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds) with 7 patents, ranking #433 of 1,741 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 15 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Elantas ranks #26,205 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 15 technology areas.

#26,205
of 49,997 US assignees by volume: 49th percentile
by Innovation Score (34.8/100): 19.2
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26205 · US Corporation #26,205 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,205/49,997
PHOTO-FINISH EKO Health
CPC-FOCUS C08G · 15 areas
INNOV-THIN 34.8/100
CLAIMS-RICH 19.2 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: EKO Health, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Elantas’s 34.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (24%) Velocity 1.3 pts (4%) Breadth 13.7 pts (39%) Claim depth 11.5 pts (33%)

Qualcomm Incorporated · highest

85
Elantas PDG · this assignee

35
3D Lighting… · lowest

7

What this shows Elantas's Innovation Score is 34.8/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Elantas?

Each dot is one of Elantas’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Elantas’s own 19.2 claims/patent is ABOVE the 12.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Elantas vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Elantas's grants concentrate

Elantas PDG is a focused PatentsView assignee: 15 CPC subclasses with 70% of grants classified under C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2023. By volume, Elantas sits between EKO Health, Inc. and Elpida Memory, Inc..

Elantas's three-year grant acceleration

Elantas PDG shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

EKO Health

10
Ekra Automatisier…

10
Ekwb d o o

10
Elantas

10
Electric Power De…

10
Electro Terminal…

10
Elobix AB

10
Elpida Memory

10
Elantas PDG ◀

10

What this shows Elantas holds 10 patents at rank #26,190, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Elantas

By rank, the assignees closest to #26,190 in granted patent volume.

Leaders in C08G (Macromolecular Compounds Obtained Otherwise Than BY React…)

Other assignees with the most granted patents in Elantas's primary technology class.

Elantas's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 49th percentile higher than 49% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Elantas PDG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	3	30.0%
2019	3	30.0%
2020	2	20.0%
2023	1	10.0%
2025partial year	1	10.0%

Which technologies does Elantas PDG patent most?

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 7

C09D - Coating Compositions, e.g. Paints, Varnishes OR LACQUERS; Filling PASTES; Chemical Paint OR INK REMOVERS; INKS; Correcting FLUIDS; WOODSTAINS; Pastes OR Solids FOR Colouring OR PRINTING; USE OF Materials Therefor 6

H01B - CABLES; CONDUCTORS; INSULATORS; Selection OF Materials FOR Their Conductive, Insulating OR Dielectric Properties 5

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 3

C09J - ADHESIVES; Non-mechanical Aspects OF Adhesive Processes IN GENERAL; Adhesive Processes NOT Provided FOR ELSEWHERE; USE OF Materials AS Adhesives 3

B01D - Separation 3

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 2

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 2

Y10T - Technical Subjects Covered BY Former US Classification 2

C08L - Compositions OF Macromolecular Compounds 1

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 1

B05D - Processes FOR Applying Fluent Materials TO Surfaces, IN General 1

H02K - Dynamo-electric Machines 1

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Elantas PDG's patent record in context - here's where to go next.

Elantas PDG's lead technology class is C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds), 70% of its portfolio - see every assignee active in that class. Explore C08G
Ranked #26,205 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Elantas PDG against EKO Health, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.